|
Study group
| | |
1 | Selection before disease was present or at uniform point | V | CH/CC |
2 | Cases and controls were drawn from the same population | V | CC |
3 | Participation rate ⩾80% for cases/cohort | V | CH/CC |
4 | Participation rate ⩾80% for controls | V | CC |
5 | Sufficient description of baseline characteristics | I | CH/CC |
|
Assessment of risk factor
| | |
6 | Exposure assessment was “blinded” | V | CH/CC |
7 | Exposure was measured identically in study group | V | CC |
8 | Exposure was assessed before the outcome | V | CH/CC |
|
Assessment of hip OA
| | |
9 | Hip OA was assessed identically in study group | V | CH/CC |
10 | Presence of hip OA was assessed reproducibly | V | CH/CC |
11 | Presence of hip OA was according to valid definitions | V | CH/CC |
12 | Classification was standardised | I | CH/CC |
|
Study design
| | |
13 | Prospective design was used | V | CH/CC |
14 | Follow up time ⩾3 years | V | CH |
15 | Withdrawals ⩽20% | V | CH |
16 | Information about completers v withdrawals | I | CH |
|
Analysis and data presentation
| | |
17 | Frequencies of most important outcomes were given | I | CH/CC |
18 | Appropriate analysis techniques were used | V | CH/CC |
19 | Adjusted for at least age and sex | V | CH/CC |